Suspension culture of human embryonic stem cells
First Claim
Patent Images
1. A method of culturing undifferentiated hES cells, comprising:
- a) suspending human embryonic stem (hES) cells in a nutrient medium;
b) maintaining the hES cells substantially undifferentiated in suspension while culturing;
c) changing the nutrient medium periodically; and
d) optionally splitting the culture from time to time so as to reduce the density of hES cells in the culture;
wherein, the nutrient medium comprises FGF2 and does not comprise added extracellular matrix; and
wherein, the hES cells are not grown on a solid substrate.
2 Assignments
0 Petitions
Accused Products
Abstract
This disclosure provides an improved system for culturing human embryonic stem cells. The cells are cultured in suspension so as to maximize the production capacity of the culture environment. The new culture system of this invention allows for bulk proliferation of hES cells in a more cost-effective manner, which facilitates commercial production of important products for use in human therapy.
31 Citations
7 Claims
-
1. A method of culturing undifferentiated hES cells, comprising:
-
a) suspending human embryonic stem (hES) cells in a nutrient medium; b) maintaining the hES cells substantially undifferentiated in suspension while culturing; c) changing the nutrient medium periodically; and d) optionally splitting the culture from time to time so as to reduce the density of hES cells in the culture; wherein, the nutrient medium comprises FGF2 and does not comprise added extracellular matrix; and wherein, the hES cells are not grown on a solid substrate. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
Specification